Home Current Issue Previous Issues Subscription Advertistment Guidelines Contact ASN

ACTA
STOMATOLOGICA

NAISSI

Table of Contents for
Jun 2016 • Volume 32 • Number 73

HOW MUCH WE KNOW ABOUT BISPHOSPHONATE LESIONS

Zoran Pešić 1,

Miloš Zarev 2,

Jovana Ranđelović 2


1Clinic of Dentistry, Department of Maxillofacial Surgery, Nis, Serbia

2University of Nis, Faculty of Medicine, PhD students
   
...Abstract


 

Introduction: Bisphosphonate drugs are used in the treatment of the osteoporosis and malignant processes in the bone tissue. As a result of this use bisphosphonate lesions are formed in bone tissue and oral mucosis,  which   representing a remarkable therapeutic problem.
The aim of this study was to determine how many dentists in general practice are familiar with the character, diagnosis and therapy bisphosphonate lesions.

Matreijal and Methods: An anonymous questionnaire of 13 questions was conducted in dental practices in Nis County in the period from October 2015 to December 2015. The obtained data were statistically analyzed.

Results: A total of 60% dentists knew what drugs are used in the treatment of osteoporosis and malignant processes in the bones. 25% knew what  the bisphosphonate bone lesions are . 66, 6% of dentists  knewn what is the prevention of bisphosphonate lesions. 63.3% of dentists are aware of the complications bisphosphonate  lesions.

Conclusion: Dentists in  general practices are insufficiently familiar with the character, diagnosis and treatment of bisphosphonate lesions. We should activate all entities that participate in more continuous medical education, in order to achieve a higher level of prevention of these therapeutic ungrateful lesions.

 

... Authors and Reprint Information

Address of correspondence:
Prof. Zoran Pešić, DDS,PhD
Dr Zoran Đinđić  Blvd.52, 18000 Niš,
phone:+38169469619
email.pesic.z@gmail.com



Copyright © 2016 by The Editorial Council of The Acta Stomatologica Naissi